{
    "organizations": [],
    "uuid": "a10cd8e5e7ffb499362f1e133430b67d593a2231",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-paxman-submits-application-for-mar/brief-paxman-submits-application-for-market-approval-in-japan-idUSFWN1RI0EJ",
    "ord_in_thread": 0,
    "title": "BRIEF-Paxman Submits Application For Market Approval In Japan",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 5 (Reuters) - PAXMAN AB (PUBL):\n* ‍EXPECTS TO BE GRANTED AN APPROVAL IN 2019 AT LATEST.​ * APPLICATION COVERS ALL SOLID TUMOURS INCLUDING BREAST CANCER Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-04-05T19:18:00.000+03:00",
    "crawled": "2018-04-06T21:46:11.031+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "paxman",
        "ab",
        "publ",
        "granted",
        "approval",
        "application",
        "cover",
        "solid",
        "tumour",
        "including",
        "breast",
        "cancer",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}